Shared genetic factors may drive both osteoarthritis and cardiovascular disease, suggesting a common genetic basis that ...

Zoetis' strategic divestiture of non-core assets and strong market position in companion animal drugs support a robust growth ...

Participants were broken into two cohorts. The first cohort received one of three doses of PCRX-201. The second cohort received concurrent pretreatment with an intraarticular corticosteroid ...

A recent study found semaglutide – the drug known as Ozempic – can improve knee pain in people with obesity and ...

Weight loss drugs like Ozempic and Wegovy may provide strong relief from severe osteoarthritis knee pain, new research finds.

Knee cartilage is not designed for high stress loads. People who are overweight or obese are at a higher risk of developing osteoarthritis because of the extra stress on their knee joints, with many ...

The study highlights BMI's role in mediating genetic risk for diseases, suggesting a complex relationship with conditions ...

Genascence Corporation ("Genascence"), a clinical-stage biotechnology company revolutionizing the treatment of prevalent ...

The following is a summary of “Impact of Structural Severity on Outcomes in Knee Osteoarthritis: An Analysis of Data from ...

The ‘Ozempic drug,’ semaglutide, has been found to reduce moderately severe pain caused by knee osteoarthritis and improve ...

In a report released today, Glen Santangelo from Jefferies maintained a Buy rating on Elanco Animal Health (ELAN – Research Report), with ...